Abstract
Background: Tumefactive demyelinating lesions (TDLS) as lesions >2cm, are one of the rare variants of multiple sclerosis (MS). There are several case reports of tdl after administration of fingolimod as first-line DMD in MS treatment. Here, we report a case of tdl following fingolimod treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
